Wild Microbes is a Freeflow Fund Two portfolio company founded by Tim Wannier who earned a PhD in Biology from Caltech and was a Postdoctoral Fellow at Harvard Medical School prior to founding Wild Microbes.

Wild Microbes is developing the first microbial index filled with the world’s most exceptional microbial hosts. BCG estimates the market for biomanufactured ingredients in three industries alone—specialty chemicals, food, and chemical precursors—could reach $200 billion by 2040. Freeflow’s investment in Wild Microbes is part of our planetary health investment thesis in biomanufacturing where everyday products are being re-imagined to achieve greater sustainability and lower production costs.

This discussion took place on Wednesday, September 25, 2024.